Lanham O'Dell & Company »

Catalyst Pharmaceutical Partners shares owned by Lanham O'Dell & Company

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Lanham O'Dell & Company from 13F filings

Historical chart of Lanham O'Dell & Company investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Lanham O'Dell & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Lanham O'Dell & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $319k 20k 15.94
2023-12-31 $347k 21k 16.81
2023-09-30 $246k 21k 11.69
2023-06-30 $282k 21k 13.44
2023-03-31 $348k 21k 16.58
2022-12-31 $372k 20k 18.60
2022-09-30 $258k 20k 12.81
2022-03-31 $220k 27k 8.30
2021-12-31 $339k 50k 6.78

More positions owned by Lanham O'Dell & Company

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Value Etf (VTV)
Spdr Ser Tr Spdr S&p 500 Etf (SPYX)
T Rowe Price Etf Cap Appreciation (TCAF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Intercontinental Exchange (ICE)
City Holding Company (CHCO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Chevron Corporation (CVX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Microsoft Corporation (MSFT)

View all positions for Lanham O'Dell & Company

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners